1CasteelsVanDaele M, Wouters C, VanGeet C, et al. Reye-syndrome revisited:a descriptive term covering a group of heterogenous disorders. Eur J Pediatr, 2000, 159:641 - 648.
2Glasgow JFT, Middleton B. Reye-syndrome:insights on causation and grognosis. Arch Dis Child, 2001, 85:351 - 353.
3Hardie RM, Newton LH, Bruce JC, et al. The changing clinical pattern of reye's syndrome. Arch Dis Child, 1996, 74:400.
4Voekey J, Whiteman DA. Defects of mitochondrial β-oxidation :a growing group of disorders. Neuromuscul Disord, 2002, 12:235 - 246.
6Bzduch V, Behulova D, Lehnert W, et al. Metabolic cause of reye-like syndrome. Bratisl Lek Listy, 2001, 102:427 - 429.
7He M, Rutledge SL, Kelly DR, et al. A new genetic disorder in mitochondrial fatty acid β- oxidation :ACAD9 deficiency. Am J Hum Genet, 2007, 81:87 - 103.
8Bennett MJ, Russell LK, Tokunaga C, et al. Reye-like syndrome resulting from novel missense mutations in mitochondrial medium-and short-chain 1-3-hydroxy-acyl-CoA dehydrogenase. Mol Genet Metab, 2006, 89:74 - 79.
9Sauer SW, Okun JG, Hoffmann GF, et al. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs onmitochondrial energy metabolism. Biochim Biophys Acta, 2008, 10:1276 - 1282.
10Lemaster JJ, Nieminen AL, Qian T, et al. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem, 1997, 174:159- 165.
